Nonclinical Evaluation of the Serum Pharmacodynamic Biomarkers HGF and Shed MET following Dosing with the Anti-MET Monovalent Monoclonal Antibody Onartuzumab
Mai, E., Zheng, Z., Chen, Y., Peng, J., Severin, C., Filvaroff, E., Romero, M., Mallet, W., Kaur, S., Gelzleichter, T., Nijem, I., Merchant, M., Young, J. C.Volume:
13
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.MCT-13-0494
Date:
February, 2014
File:
PDF, 574 KB
english, 2014